Date Study Auteur
Août 2018 Evaluation of NovaSure® global endometrial ablation in symptomatic adenomyosis: A longitudinal study with a 36 month follow-up. Philip CA, Le Mitouard M, Maillet L, de Saint-Hilaire P, Huissoud C, Cortet M, Dubernard G.
Avr. 2018 Efficacy and patient satisfaction after NovaSure and Minerva endometrial ablation for treating abnormal uterine bleeding: a retrospective comparative study. Scordalakes C, delRosario R, Shimer A, Stankiewicz R.
Mar. 2018 Predictors of Long-Term NovaSure Endometrial Ablation Failure. Lybol C, van der Coelen S, Hamelink A, Bartelink LR, Nieboer TE.
Avr. 2017 Abnormal uterine bleeding control by sequential application of hysteroscopic lesion morcellation and endometrial ablation Rubino RJ et al
Sep. 2017 Long-term Follow-up After Endometrial Ablation in Finland: Cancer Risks and Later Hysterectomies. Soini T, Rantanen M, Paavonen J, Grénman S, Mäenpää J, Pukkala E, Gissler M, Hurskainen R.
Nov. 2016 Effect of Radiofrequency Endometrial Ablation on Dysmenorrhea. Wyatt SN, Banahan T, Tang Y, Nadendla K, Szychowski JM, Jenkins TR.
Nov. 2016 Effectiveness of thermal balloon ablation versus NovaSure endometrial ablation in different age groups N. HussainG. BarnesN. L. Aziz.
Sep. 2016 Outcomes and Postoperative Complications After Hysterectomies Performed for Benign Compared With Malignant Indications. Wallace SK, Fazzari MJ, Chen H, Cliby WA, Chalas E.
Mai 2016 Is endometrial ablation protective against endometrial cancer? A retrospective observational study. Singh M, Hosni MM, Jones SE.
Fév. 2016 Effects of Endometrial Ablation on Treatment Planning in Women With Endometrial Cancer. Argall E, Jovanovic A, Figueroa R, Mayer A, Nelson B, Roland P.
Fév. 2016 Hysteroscopic local anesthetic intrauterine cornual block in office endometrial ablation: a randomized controlled trial. Kumar V, Tryposkiadis K, Gupta JK.
Jan. 2016 Bipolar versus balloon endometrial ablation in the office: a randomized controlled trial. Penninx JP, Herman MC, Kruitwagen RF, Ter Haar AJ, Mol BW, Bongers MY.
Nov. 2015 Combined Endometrial Ablation and Levonorgestrel Intrauterine System Use in Women With Dysmenorrhea and Heavy Menstrual Bleeding: Novel Approach for Challenging Cases Papadakis EP, El-Nashar SA, Laughlin-Tommaso SK, Shazly SA1, Hopkins MR, Breitkopf DM, Famuyide AO.
Août 2015 Levonorgestrel-releasing intrauterine system and the risk of breast cancer: A nationwide cohort study. Soini T, Hurskainen R, Grénman S, Mäenpää J, Paavonen J, Joensuu H, Pukkala E.
Mar. 2015 Use of other treatments before hysterectomy for benign conditions in a statewide hospital collaborative. Corona LE, Swenson CW, Sheetz KH3, Shelby G, Berger MB, Pearlman MD2, Campbell DA Jr, DeLancey JO, Morgan DM.
Fév. 2015 Effect of undiagnosed deep adenomyosis after failed NovaSure endometrial ablation. Mengerink BB, van der Wurff AA, ter Haar JF, van Rooij IA, Pijnenborg JM.
Sep. 2014 Endometrial cancer after endometrial ablation vs medical management of abnormal uterine bleeding. Dood RL, Gracia CR, Sammel MD, Haynes K, Senapati S, Strom BL.
Août 2014 Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland. Soini T, Hurskainen R, Grénman S, Mäenpää J, Paavonen J, Pukkala E.
Août 2014 Comparative efficacy of NovaSure, the Levonorgestrel-releasing intrauterine system, and hysteroscopic endometrial resection in the treatment of menorrhagia: a randomized clinical trial S. Ghazizadeh, Z. Panahi, Z. Ghanbari, AT. Menshadi, T. Farahmandian, P. Javadian
Mar. 2014 Ultrasound-guided reoperative hysteroscopy for managing global endometrial ablation failures. Wortman M, Daggett A, Deckman A.
Mar. 2014 Ten-year literature review of global endometrial ablation with the NovaSure device Gimpelson RJ
Fév. 2014 Endometrial Cancer After Endometrial Ablation vs Medical Management of Abdnormal Uterine Bleeding Robert L. Dood, Clarisa R. Gracia, Mary D. Sammel, Kevin Haynes, Suneeta Senapati, Brian L. Strom
Nov. 2013 Radiofrequency endometrial ablation in patients with a history of low transverse cesarean delivery. Adkins RT, Bressman PL, Bressman PB, Lucas TL.
Sep. 2013 Endometrial Ablation: Is Tubal Ligation a Risk Factor for Hysterectomy Kreider SE, Starcher R, Hoppe J, Nelson K, Salas N.
Juil. 2013 Ten-year follow-up of a randomised controlled trial comparing bipolar endometrial ablation with balloon ablation for heavy menstrual bleeding. Herman MC, Penninx JP, Mol BW, Bongers MY.
Oct. 2012 Minimally Invasive Endometrial Ablation Device Complications and Use Outside of the Manufacturers' instructions J. Brown, K. Blank
Juil. 2012 Hysterectomy subsequent to endometrial ablation. Shavell VI, Diamond MP, Senter JP, Kruger ML, Johns DA.
Avr. 2012 Second generation endometrial ablation techniques for heavy menstrual bleeding: network meta-analysis J.P. Daniels, L.J. Middleton, R. Champaneria, K.S. Khan, K. Cooper, B.W.J. Mol, S. Bhattacharya
Déc. 2011 Five-year follow-up after comparing bipolar endometrial ablation with hydrothermablation for menorrhagia Penninx JP, Herman MC, Mol BW, Bongers MY
Nov. 2011 Efficacy and safety of global endometrial ablation after cesarean delivery: a cohort study. Khan Z, El-Nashar SA, Hopkins MR, Famuyide AO.
Nov. 2011 Bipolar Radiofrequency Compared With Thermal Balloon Endometrial Ablation in the Office T. Justin Clark, Nadia Samuel, Sadia Malick, G, Lee J. Middleton, Jane Daniels, Janesh K. Gupta
Sep. 2011 Improved premenstrual syndrome symptoms after NovaSure endometrial ablation. Lukes AS, McBride RJ, Herring AH, Fried M, Sherwani A, Dell D.
Août 2011 Global-local anaesthesia: combining paracervical block with intramyometrial prilocaine in the fundus significantly reduces patients' perception of pain during radio-frequency endometrial ablation (NovaSure) in an office setting H. Skensved et al.
Juil. 2011 Endometrial ablation with the NovaSure system in Iran Asgari Z, Moini A, Samiee H, Tehranian A, Mozafar-Jalali S, Sabet S.
Jan. 2011 Pathologic characteristics of hysterectomy specimens in women undergoing hysterectomy after global endometrial ablation. Carey ET, El-Nashar SA, Hopkins MR, Creedon DJ, Cliby WA, Famuyide AO.
Jan. 2011 Five-Year Follow Up of a Randomised Controlled Trial Comparing NovaSure® and ThermaChoice™ Endometrial Ablation T. Justin Clark, Nadia Samuel, Sadia Malick, Lee J. Middleton, Jane Daniels, Janesh K. Gupta
Oct. 2010 Bipolar radiofrequency endometrial ablation compared with hydrothermablation for dysfunctional uterine bleeding: a randomized controlled trial. Penninx JP, Mol BW, Engels R, van Rumste MM, Kleijn C, Koks CA, Kruitwagen RF, Bongers MY.
Avr. 2010 Health-related quality of life and patient satisfaction after global endometrial ablation for menorrhagia in women with bleeding disorders: a follow-up survey and systematic review. El-Nashar SA, Hopkins MR, Barnes SA, Pruthi RK, Gebhart JB, Cliby WA, Famuyide AO.
Nov. 2009 Feasibility of endometrial assessment after thermal ablation. Ahonkallio SJ, Liakka AK, Martikainen HK, Santala MJ.
Oct. 2009 Endometrial Ablation with Paracervical Block Josien P. M. Penninx, Prof., M.D., Ben Willem Mol, M.D., Marlies Y. Bongers, M.D.
Jan. 2009 Prediction of treatment outcomes after global endometrial ablation. El-Nashar SA, Hopkins MR, Creedon DJ, St Sauver JL, Weaver AL, McGree ME, Cliby WA, Famuyide AO.
Juin 2007 Global endometrial ablation for menorrhagia in women with bleeding disorders. El-Nashar SA, Hopkins MR, Feitoza SS, Pruthi RK, Barnes SA, Gebhart JB, Cliby WA, Famuyide AO.
Juin 2007 Radiofrequency global endometrial ablation followed by hysteroscopic sterilization Matthew R. Hopkins, MD, Douglas J. Creedon, MD, PhD, Sherif A. El-Nashar, MBBCh, MSc, Douglas L. Brown, MD, Andrew E. Good, MD, Abimbola O. Famuyide, MBBS
Juin 2007 An impedance-controlled system for endometrial ablations: five-year follow-up of 107 patients. Gallinat A.
Jan. 2007 NovaSure impedance controlled endometrial ablation: long-term follow-up results. Fulop T, Rákóczi I, Barna I.
Juin 2006 Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intracavitary disease: 12-month follow-up results of a prospective, single-arm clinical study Robert Sabbah, MD, and Gilles Desaulniers, MD
Déc. 2005 Thermal Endometrial Ablation in Dysfunctional Uterine Bleeding: An Economic Comparison of Bipolar Ablation and Balloon Ablation Bongers M.Y., Bourdrez P., Heintz A.P., Steeg J.W., Brolmann H.A., Mol B.W.
Juin 2005 A randomized trial among women with heavy menstruation -- impact of a decision aid on treatment outcomes and costs. Vuorma S, Teperi J, Aalto AM, Huskainen R, Kuhansuu E, Rissanen P.
Juin 2005 Long-term treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection. Rauramo I, Elo I, Istre O.
Juin 2005 A randomised comparison of medical and hysteroscopic management in women consulting a gynaecologist for treatment of heavy menstrual loss. Cooper KG, Parkin DE, Garratt AM, Grant AM.
Mai 2005 NovaSure bipolar radiofrequency endometrial ablation: report of 200 cases. Baskett TF, Clough H, Scott TA.
Nov. 2004 NovaSure impedance controlled system for endometrial ablation: three-year follow-up on 107 patients. Gallinat A
Mai 2004 Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysteroctomy for treatment of menorrhagia: randomized trial 5-year follow-up Hurskainen R, Teperi J, Rissanen P, Aalto AM, Grenman S, Kivelä A, Kujansuu E, Vuorma S, Yliskoski M, Paavonen J.
Avr. 2004 Summary of safety and effectiveness data from FDA: a valuable source of information on the performance of global endometrial ablation devices. Cooper J, Gimpelson RJ.
Juil. 2003 A double-blind randomized trial comparing the Cavaterm and the NovaSure endometrial ablation systems for the treatment of dysfunctional uterine bleeding. Abbott J, Hawe J, Hunter D, Garry R.
Mai 2003 A Look at Intra- and Post-Operative Pain Assessment with ThermaChoice™ versus NovaSure® Endometrial Ablation Systems Laberge, P., Sabbah, R., Fortin, C., Galliant, A.
Jan. 2003 Endometrial ablation with NovaSure GEA, a pilot study. Busund B, Erno LE, Grønmark A, Istre O.
Nov. 2002 A randomized, multicenter trial of safety and efficacy of the NovaSure system in the treatment of menorrhagia. Cooper J, Gimpelson R, Laberge P, Galen D, Garza-Leal JG, Scott J, Leyland N, Martyn P, Liu J.

Produits Pertinents


Hystéroscope Omni





Des questions ? Appelez-nous au 0 800 913 659

Le contenu de ce site est exclusivement réservé aux professionnels de santé.

Oui Je suis un professionnel de santé ou assimilé.
Non Je ne suis pas un professionnel de santé ou assimilé.